Growth Metrics

Compass Therapeutics (CMPX) Depreciation and Depletion (2023 - 2026)

Compass Therapeutics' Depreciation and Depletion history spans 4 years, with the latest figure at $15000.0 for Q1 2026.

  • On a quarterly basis, Depreciation and Depletion fell 89.29% to $15000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $175000.0, a 67.59% decrease, with the full-year FY2025 number at $300000.0, down 50.0% from a year prior.
  • Depreciation and Depletion hit $15000.0 in Q1 2026 for Compass Therapeutics, down from $100000.0 in the prior quarter.
  • Over the last five years, Depreciation and Depletion for CMPX hit a ceiling of $200000.0 in Q1 2023 and a floor of $15000.0 in Q1 2026.
  • Historically, Depreciation and Depletion has averaged $134583.3 across 4 years, with a median of $120000.0 in 2023.
  • Biggest five-year swings in Depreciation and Depletion: skyrocketed 100.0% in 2024 and later crashed 89.29% in 2026.
  • Tracing CMPX's Depreciation and Depletion over 4 years: stood at $200000.0 in 2023, then crashed by 50.0% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then crashed by 85.0% to $15000.0 in 2026.
  • Business Quant data shows Depreciation and Depletion for CMPX at $15000.0 in Q1 2026, $100000.0 in Q3 2025, and $60000.0 in Q2 2025.